Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

10355	Companies
215502	Keywords
145322	Articles
114166	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 10/13/2025 at 07:00, 6 months 24 days ago

BIOPHYTIS and a Consortium of Investors including RONGHUI RENHE Life Technology Join Forces to Finance and Launch First-Ever Phase 3 Trial in Sarcopenia
BIOPHYTIS and a Consortium of Investors partner to finance and launch Phase 3 Trial in Sarcopenia, creating a joint venture in Hong Kong with US$20 million investment for clinical operations starting early 2026

Biophytis Joint Venture Phase 3 Trial Sarcopenia Consortium Of Investors
BRIEF

published on 09/30/2025 at 07:05, 7 months 6 days ago

Biophytis to Engage in Key Events in Q4 2025

Biophytis Partnerships Longevity Sarcopenia Biotechnology Events
REGULATED PRESS RELEASE

published on 09/30/2025 at 07:00, 7 months 6 days ago

Biophytis to Participate in Four Key Events in Q4 2025
Biophytis to participate in four major international events in Q4 2025, showcasing its progress in transformative therapies impacting longevity and seeking new partnerships

Biophytis Partnerships Longevity International Events Transformative Therapies
BRIEF

published on 09/15/2025 at 07:05, 7 months 21 days ago

Biophytis Secures Funding for Obesity Trial in Brazil

Biophytis Brazil Obesity Trial EMBRAPII Clinical Partnerships
REGULATED PRESS RELEASE

published on 09/15/2025 at 07:00, 7 months 21 days ago

Biophytis Secures public funding in Brazil for Obesity Phase 2 Trial and Signs Agreements with Leading local Clinical Partners
Biophytis secures public funding in Brazil for Obesity Phase 2 trial and signs agreements with leading local clinical partners, strengthening its OBA Phase 2 program and obtaining non-dilutive funding support through EMBRAPII

Biophytis Public Funding EMBRAPII Obesity Phase 2 Trial Clinical Partners
BRIEF

published on 09/11/2025 at 07:05, 7 months 25 days ago

Biophytis Announces Phase 3 Sarcopenia Trial for BIO101 in Europe and Asia

Age-related Diseases BIO101 Sarcopenia Clinical Trial Biophytis Strategy Asia And Europe
REGULATED PRESS RELEASE

published on 09/11/2025 at 07:00, 7 months 25 days ago

Biophytis unveils Phase 3 Sarcopenia Trial Strategy with BIO101 in Europe and Asia
Biophytis announces Phase 3 Sarcopenia Trial Strategy with BIO101 targeting age-related sarcopenia in Europe and Asia, aiming to address a significant unmet medical need and commercial market

Biophytis Clinical Trial Sarcopenia Phase 3 BIO101
BRIEF

published on 09/03/2025 at 07:05, 8 months 3 days ago

Biophytis Advances Obesity Treatment with EMA Approval

Biophytis Obesity Treatment Clinical Trial BIO101 EMA Authorization
REGULATED PRESS RELEASE

published on 09/03/2025 at 07:00, 8 months 3 days ago

Biophytis obtains EMA authorization to launch its Phase 2 clinical trial in obesity
Biophytis obtains EMA authorization to launch Phase 2 clinical trial of BIO101 in obesity, marking a significant regulatory milestone in Europe

Biophytis Phase 2 Clinical Trial Obesity EMA Authorization Regulatory Milestone
BRIEF

published on 09/01/2025 at 07:05, 8 months 5 days ago

Biophytis Announces Phase 2 Obesity Trial with BIO101

Biophytis Phase 2 Trial BIO101 Obesity Muscle Wasting

Accesswire

Published on 05/07/2026 at 02:00, 16 minutes ago

Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 2 hours 46 minutes ago

Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 3 hours 11 minutes ago

Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 3 hours 16 minutes ago

Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/06/2026 at 22:10, 4 hours 6 minutes ago

Banyan Gold Announces Closing of $46.5 Million Private Placement

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 00:47, 1 hour 29 minutes ago

Blue Cap AG expands portfolio through the acquisition of Janoschka AG
Published on 05/07/2026 at 00:43, 1 hour 33 minutes ago

EQS-Adhoc: Blue Cap AG Acquires Janoschka AG and Adjusts Forecast Due to Transaction
Published on 05/06/2026 at 20:32, 5 hours 44 minutes ago

EQS-Adhoc: Kontron AG: ADHOC Kontron AG / Potential Public Takeover Bid by Ennoconn Corporation
Published on 05/06/2026 at 20:22, 5 hours 54 minutes ago

EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers strong Q1 results, enters AI market through a development agreement with a leading AI photonics customer and sees path to positive Free Cash Flow in 2027
Published on 05/06/2026 at 19:18, 6 hours 58 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/06/2026 at 18:00, 8 hours 16 minutes ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 8 hours 16 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 17:45, 8 hours 31 minutes ago

Information concerning the total number of voting rights and shares 2026 04 30
Published on 05/06/2026 at 17:45, 8 hours 31 minutes ago

Declaration of voting rights at the end of April 2026
Published on 05/06/2026 at 17:45, 8 hours 31 minutes ago

Accor - Information regarding availability and consultation of preparatory documents - Shareholders' Meeting of May 27, 2026

View all LES ECHOS COMFI WIRE